Aytu BioScience (AYTU) Reports Q2 Loss of $0.89

February 8, 2018 4:03 PM

Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($0.89), versus ($1.78) reported last year. Revenue for the quarter came in at $1.05 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

Categories

Corporate News Earnings Guidance